
|Articles|August 15, 2002
Patients satisfied with improved contrast sensitivity of IOL
Philadelphia-The Tecnis Z9000 IOL (Pharmacia) performed well in a clinical trial by providing improved contrast sensitivity compared with a conventional IOL. In addition, in a model eye the Tecnis IOL also improved the optical performance by compensating for corneal aberrations.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























